Geode Capital Management
REGN icon

Geode Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.29B Sell
2,465,054
-4,531
-0.2% -$2.37M 0.09% 189
2025
Q1
$1.56B Buy
2,469,585
+41,955
+2% +$26.5M 0.12% 141
2024
Q4
$1.73B Buy
2,427,630
+155,369
+7% +$111M 0.13% 122
2024
Q3
$2.38B Sell
2,272,261
-143,089
-6% -$150M 0.19% 89
2024
Q2
$2.53B Buy
2,415,350
+38,759
+2% +$40.6M 0.22% 76
2024
Q1
$2.28B Buy
2,376,591
+22,374
+1% +$21.5M 0.21% 82
2023
Q4
$2.06B Buy
2,354,217
+34,231
+1% +$30M 0.22% 82
2023
Q3
$1.91B Buy
2,319,986
+38,857
+2% +$31.9M 0.23% 79
2023
Q2
$1.64B Buy
2,281,129
+63,136
+3% +$45.3M 0.19% 94
2023
Q1
$1.82B Buy
2,217,993
+10,003
+0.5% +$8.2M 0.24% 80
2022
Q4
$1.59B Sell
2,207,990
-32,123
-1% -$23.1M 0.22% 87
2022
Q3
$1.54B Buy
2,240,113
+26,009
+1% +$17.9M 0.23% 76
2022
Q2
$1.31B Buy
2,214,104
+121,333
+6% +$71.6M 0.19% 95
2022
Q1
$1.46B Buy
2,092,771
+115,469
+6% +$80.5M 0.18% 98
2021
Q4
$1.25B Buy
1,977,302
+237,090
+14% +$149M 0.15% 115
2021
Q3
$1.05B Buy
1,740,212
+32,212
+2% +$19.4M 0.14% 124
2021
Q2
$951M Buy
1,708,000
+97,810
+6% +$54.5M 0.13% 131
2021
Q1
$760M Buy
1,610,190
+23,271
+1% +$11M 0.12% 151
2020
Q4
$765M Sell
1,586,919
-170,067
-10% -$81.9M 0.13% 136
2020
Q3
$982M Buy
1,756,986
+235,853
+16% +$132M 0.19% 96
2020
Q2
$947M Buy
1,521,133
+188,616
+14% +$117M 0.2% 92
2020
Q1
$649M Buy
1,332,517
+65,789
+5% +$32.1M 0.17% 121
2019
Q4
$475M Buy
1,266,728
+25,165
+2% +$9.43M 0.1% 200
2019
Q3
$344M Buy
1,241,563
+81,002
+7% +$22.4M 0.08% 253
2019
Q2
$363M Buy
1,160,561
+62,713
+6% +$19.6M 0.09% 231
2019
Q1
$450M Buy
1,097,848
+19,395
+2% +$7.95M 0.12% 179
2018
Q4
$402M Buy
1,078,453
+78,143
+8% +$29.1M 0.12% 161
2018
Q3
$403M Buy
1,000,310
+29,493
+3% +$11.9M 0.11% 169
2018
Q2
$334M Buy
970,817
+34,841
+4% +$12M 0.1% 193
2018
Q1
$322M Buy
935,976
+55,495
+6% +$19.1M 0.1% 193
2017
Q4
$330M Buy
880,481
+30,581
+4% +$11.5M 0.11% 183
2017
Q3
$379M Buy
849,900
+20,395
+2% +$9.1M 0.14% 138
2017
Q2
$407M Buy
829,505
+97,071
+13% +$47.6M 0.16% 122
2017
Q1
$283M Buy
732,434
+62,796
+9% +$24.3M 0.12% 178
2016
Q4
$246M Buy
669,638
+31,097
+5% +$11.4M 0.11% 176
2016
Q3
$256M Buy
638,541
+1,979
+0.3% +$794K 0.13% 155
2016
Q2
$222M Sell
636,562
-4,248
-0.7% -$1.48M 0.12% 167
2016
Q1
$231K Buy
640,810
+14,289
+2% +$5.14K 0.12% 156
2015
Q4
$339M Buy
626,521
+5,085
+0.8% +$2.75M 0.19% 104
2015
Q3
$288M Buy
621,436
+20,244
+3% +$9.4M 0.18% 114
2015
Q2
$306M Buy
601,192
+18,970
+3% +$9.66M 0.17% 115
2015
Q1
$262M Buy
582,222
+19,294
+3% +$8.7M 0.15% 134
2014
Q4
$231M Buy
562,928
+24,929
+5% +$10.2M 0.14% 149
2014
Q3
$194M Sell
537,999
-41,519
-7% -$14.9M 0.13% 161
2014
Q2
$164M Buy
579,518
+3,446
+0.6% +$973K 0.11% 195
2014
Q1
$173M Buy
576,072
+4,195
+0.7% +$1.26M 0.12% 179
2013
Q4
$157M Buy
571,877
+21,813
+4% +$6M 0.11% 189
2013
Q3
$172M Buy
550,064
+30,553
+6% +$9.56M 0.14% 147
2013
Q2
$117M Buy
+519,511
New +$117M 0.1% 204